About Capital Rx
What Capital Rx is building
Technologies used at Capital Rx
Python
AWS
SQL
GitCompany culture
HONEST
We believe in doing the right thing even when no one is watching, because in the healthcare industry trust is important. We promise to always do right by you, so you’ll be proud to work with us.
CARING
We're committed to going above and beyond for our clients, members, and employees. Our goal is to instill quality and consideration in everything we do, from our service to our products and technology.
Funding rounds
Total Funding
Last funding round type
Company type
Capital Rx news and updates
Capital Rx, Inc. received award Validation for Contractual Integrity on Dec 8th 22'.
Earlier this year, Capital Rx was awarded Validation for Contractual Integrity by Validation Institute, which certified the transparency of Capital Rx's model contract.
Dec 7, 2022 | cap-rx.comCapital Rx, Inc. hired Lloyd Fiorini as General Counsel and Chief Compliance Officer on Nov 24th 22'.
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, today announced that Lloyd Fiorini has joined the company as General Counsel and Chief Compliance Officer.
Nov 23, 2022 | ccbjournal.comCapital Rx, Inc. launched Capital Rx on Jan 1st 17'.
“When Capital Rx, Inc. first launched Capital Rx in 2017, Capital Rx, Inc. quickly realized that to deliver superior service, Capital Rx, Inc. couldn’t rely on the technology solutions found in the marketplace,” said Ryan Kelly, Chief Technology Officer of Capital Rx.
Nov 14, 2022 | cap-rx.comCapital Rx, Inc. launched JUDI on Jan 1st 21'.
In 2021, Capital Rx launched JUDI™, an intuitive, cloud-native, API-based enterprise pharmacy platform (EPP), the first of its kind in the pharmacy industry.
Sep 13, 2022 | stevieawards.comCapital Rx, Inc. recognized as No. 33 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America
Today, Inc. revealed that Capital Rx is No. 33 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.
Aug 15, 2022 | cap-rx.comGeneral Catalyst invested into Capital Rx, Inc. in $106M on Jun 13th 22'.
Capital Rx, a health technology company changing the way prescription drugs are priced and patients are serviced, today announced the close of its $106M Series C funding led by B Capital, with participation from General Catalyst and existing investors, Transformation Capital and Edison Partners.
Jun 12, 2022 | cap-rx.comCapital Rx, Inc. received award Bronze Stevie® Award for Will Tafoya at 16th annual Stevie Awards for Sales & Customer Service on Feb 3rd 22'.
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, was presented with a Bronze Stevie® Award for Will Tafoya, Capital Rx’s SVP of Customer Care, in the Customer Service Leader of the Year category during the 16th annual Stevie Awards for Sales & Customer Service.
Jan 1, 2022 | cap-rx.comCapital Rx, Inc. launched Customer Care Contact Center on Jan 1st 21'.
Capital Rx launched its Customer Care Contact Center in January 2021 to provide the best possible service experience for its clients.
Jan 1, 2022 | cap-rx.comAJ Loiacono at Capital Rx, Inc. receives award Gold Winner in the Healthcare Technology Solution category for this year's Stevie Awards at The 20th Annual American Business Awards®
"Capital Rx, Inc. is honored to be recognized as a Gold Winner in the Healthcare Technology Solution category for this year's Stevie Awards," said CEO AJ Loiacono.
Jan 1, 2022 | cap-rx.comAJ Loiacono at Capital Rx, Inc. recognized as Entrepreneur Of The Year® 2022 New York Award finalist
Ernst & Young LLP (EY US) announced that AJ Loiacono, CEO and co-founder of Capital Rx was named an Entrepreneur Of The Year® 2022 New York Award finalist.
Jan 1, 2022 | cap-rx.comCapital Rx, Inc. received financing of $106M in Series C funding on Jun 13th 22'.
On June 13, 2022, Capital Rx, a health technology company, announced that it has secured $106M in Series C funding.
Jan 1, 2022 | wilmerhale.comB Capital Group invested into Capital Rx, Inc. in $106M on Jun 13th 22'.
Capital Rx, a health technology company changing the way prescription drugs are priced and patients are serviced, today announced the close of its $106M Series C funding led by B Capital, with participation from General Catalyst and existing investors, Transformation Capital and Edison Partners.
Jan 1, 2022 | cap-rx.comCapital Rx Earns Full URAC Accreditation in Pharmacy Benefit Management
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, is proud to announce that it has earned full accreditation from the Utilization Review Accreditation Commission (URAC).
Oct 12, 2021 | PR NewswirePeople moves: Summit Health, Novant Health, Capital Rx
Jeff Alter is the new CEO of Summit Health. Alter was previously Executive Vice President of Anthem Health Solutions and President of IngenioRx, Anthem’s pharmacy business. Before this he was the CEO of UnitedHealthcare’s Commercial Group.
Oct 11, 2021 | Healthcare GlobalCapital Rx Adds Chief Financial Officer with Health Plan Experience
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are serviced, today announced that it has hired Ari Fischel as its Chief Financial Officer.
Oct 5, 2021 | PR Newswire